Eliminate the requirement of a separate section for narcotics and psychotropic drugs
Reform IDF340
DescriptionBefore: Manufacturers were required by DRAP to establish a separate section for producing narcotic and psychotropic drugs, creating unnecessary financial and operational burdens and causing production delays, despite no such requirement in INCB guidelines.
After: The requirement for a separate manufacturing section for narcotic and psychotropic drugs has been eliminated, reducing compliance costs, streamlining production processes, and aligning regulations with international standards set by the INCB.
DepartmentDrug Regulatory Authority of Pakistan - DRAP
Jurisdiction / LocationFederal - Entire Pakistan
SectorPharmaceuticals and Healthcare
Start Date24-06-2025
Target Deadline30-06-2025
Date Enacted25-08-2025
Implementation StatusCompleted
Progress 100%
CCORR DirectionSimplify
Cost Savings PKR (Mil.)36
EvidenceView Evidence